Head-to-Head Trial in Relapsing MS - Poll - MDSpire

Head-to-Head Trial in Relapsing MS

The phase 3 OVERLORD-MS trial compared 2 anti-CD20 therapies in previously untreated adults with newly diagnosed relapsing multiple sclerosis and recent inflammatory disease activity.

  • By

  • Kathryn Wighton

  • July 7, 2026

  • 6 min

Share

Original Source(s)

Head-to-Head Trial in Relapsing MS

  • by Kathryn Wighton

  • July 7, 2026

Related Content

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis

Cholinergic regulation of neuroinflammation: linking microglia, immunometabolism, and neuromodulation

Mechanisms and therapeutic advances of gut metabolites in the regulation of neuroimmune inflammatory diseases